Investors are rushing into the relative safe haven of the bond market, causing the yield on the U.S. 10-year Treasury to plummet.Real Estateread more
President Donald Trump on Thursday directed the U.S. intelligence community to "quickly and fully cooperate" with Attorney General William Barr's investigation into the...Politicsread more
Despite a decline in global commercial real estate markets, Asia-Pacific continues to enjoy a record-breaking growth — thanks to China, according to the Global Capital Flows...Real Estateread more
The Wall Street Journal and The New York Times, citing people familiar with the deal, reported that $30 million would go to plaintiffs and $14 million would be used to pay...Entertainmentread more
TransferWise, the money transfer start-up, was valued at $3.5 billion after investors bought $292 million of shares in a secondary sale.Technologyread more
Assets under management at Swiss private bank Julius Baer rose 12% in the first four months of 2019 to a record 427 billion Swiss francs ($425.34 billion).Earningsread more
Wall Street is becoming convinced that both the White House and Beijing are willing to engage in a protracted trade war that could begin to hit consumers and slow global...Market Insiderread more
The U.S. Commerce Department said its proposed rule would amend the normal countervailing duty process to include new criteria for currency undervaluation.World Economyread more
SpaceX sent 60 satellites into space in a key first mission toward the company's own high-speed internet network.Internetread more
Zilingo founder Ankiti Bose says working as an investment analyst helped her build her near-$1 billion fashion start-up.Ditching the Corporate Liferead more
Asia Pacific markets were mostly in negative territory on Friday morning as investors remained worried over trade tensions between the United States and China.Asia Marketsread more
Arch Coal, Inc.: "Coal is enjoying a bit of a renaissance, I have to admit. I am not a fan of the coal stocks, but these guys have fixed their balance sheet. I just don't want to overstate because even utilities in this country aren't that interested in it, so I say don't buy."
Visteon Corp.: "We spoke to Magna and it didn't leave me feeling so warm and fuzzy about this auto parts group, so I've got to tell you, as much as I hate to be part of the maddening crowd, I have to be careful. "
Transenterix, Inc.: "I like Intuitive Surgical. Let the others come up to be Intuitive Surgical. You know, I did Mazor, we made some money, and now I don't want to try a new one because they're just too darn hard. I say stick with ISRG. "
Duke Energy Corp.: "I don't want to be in Duke right now. The one I want to be in is American Electric Power. I want to be in ConEd. Those are the ones that have been best for me and I'm going to stick with those. And please be careful with Southern, because the overage on this building of the Vogtle nuclear plants? No. Not for me. "
Greed Dot Corp.: "I would describe it as being a financial tech play, fintech, and therefore I like it even though I know it hit a 52-week high."
The Sherwin-Williams Company: "You're going to take out the capital that you put in, then you're going to play the rest with the house's money."
AbbVie, Inc.: "I like AbbVie. I know there's a lot of bear stories running around. It's the other component of Abbott. Abbott's owned by the charitable trust. I think that it's good. I know they had one big drug that a lot of people are worried about from the biosimilar situation. I'm not as worried. I think AbbVie's a buy. "
Buckeye Partners, L.P.: "No. I mean, look, I've known Buckeye forever and you know I've soured on the pipeline group. Yeah, it's getting a little bit better, but I'm going to say there's just too much hit or miss in this group."
Axon Enterprise: "I think the stock went up and it was heavily shorted. Now it's come down a lot and I think, frankly, it's a buy."
Apptio, Inc.: "They may be the vertical. They may be the cloud situation for benchmarking. And I've got to hand it to them and I'd like to have them on the show."
Disclosure: Cramer's charitable trust owns shares of Abbott Laboratories.